Page 278 - fbkCardioDiabetes_2017

254 Cardio Diabetes Medicine 2017

diabetes mellitus (from the Action to Control Cardiovascular Risk in
Diabetes Study). Am J Cardiol 2014; 114: 1217-1222
15. Balkau B, Jouven X, Ducimetière P, Eschwège E. Diabetes as a risk
factor for sudden death. Lancet 1999; 354: 1968-1969
16. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB, Wilson
PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA
2004; 292: 2495-2499
17. Cardoso CR, Salles GF, Deccache W. Prognostic value of QT interval pa-
rameters in type 2 diabetes mellitus: results of a long-term follow-up
prospective study. J Diabetes Complications 2003; 17: 169-178
18. Molon G, Costa A, Bertolini L, Zenari L, Arcaro G, Barbieri E, Targher
G. Relationship between abnormal microvolt T-wave alternans and poor
glycemic control in type 2 diabetic patients. Pacing Clin Electrophysiol
2007; 30: 1267-1272
19. Movahed M-R. Diabetes as a risk factor for cardiac conduction defects: a
review. Diabetes, Obesity and Metabolism, 9, 2007, 276–281
20. Schneider JF, Thomas HE Jr, Sorlie P, et al. Comparative features of newly
acquired left and right bundle branch block in the general population: the
Framingham study. Am J Cardiol 1981; 47: 931 940
21. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for
the management of heart failure: a report of the American College of
Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation. 2013;128:e240–327
22. Steinberg BA, Al-Khatib SM, Edwards R, et al. Outcomes of implantable
cardioverter-defibrillator use in patients with comorbidities: results from a
combined analysis of 4 randomized clinical trials. JACC Heart Fail. 2014
Dec;2(6):623-9
23. Podlaha R, Falk A. The prevalence of diabetes mellitus and other risk
factors of atherosclerosis in bradycardia requiring pacemaker treatment.
Horm Metab Res Suppl 1992; 26: 84–87
24. Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben-Ye-
huda O, Mintz GS, Stone GW. Incidence, Predictors, and Outcomes of
High-Grade Atrioventricular Block in Patients With ST-Segment Eleva-
tion Myocardial Infarction Undergoing Primary Percutaneous Coronary
Intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2017 May
1;119(9):1295-1301

GCDC 2017